HOBOKEN, N.J.–(BUSINESS WIRE)–Castor, a number one supplier of scientific trial expertise to democratize scientific analysis, introduced two government appointments to speed up the corporate’s progress and affect on the business. Kimberly Tableman joins Castor as Chief Scientific Growth Officer (CCDO) and Anna Wozniak as Chief Monetary & Growth Officer (CFDO).
Castor’s new CCDO, Kimberly Tableman, brings greater than 23 years of expertise in scientific improvement and expertise. Over the previous decade, she has centered on making use of digital well being applied sciences to reimagine the affected person journey. She was most not too long ago CEO at Drugs X, and co-founder at Rabble Well being, the place she led the event and beta launch of a affected person engagement platform to serve oncology sufferers. Previous to Drugs X, Kimberly held senior roles at GlaxoSmithKline (GSK), together with Head of Affected person Engagement and Head of Digital Scientific Trials. She has additionally labored at Pfizer, and started her profession in administration consulting at Cap Gemini Ernst & Younger.
“I’m passionately dedicated to serving various sufferers via merchandise that facilitate a constructive analysis journey and improve accessibility to precision-medicine remedies,” stated Tableman. “I’m thrilled to be part of the Castor staff and to work alongside friends who’re equally devoted to creating patient-centric trials a actuality.”
Anna Wozniak, Castor’s new CFDO, brings greater than 14 years of life sciences expertise, constructing and scaling companies via her deal with technique, management, and driving execution. Anna was beforehand Government Vice President Technique and Growth at BC Platforms, a customized medication firm, driving progress post-Sequence A via Sequence C. Earlier than becoming a member of BC Platforms, she held numerous finance and technique roles at Syngenta.
“Castor’s technology-first method to patient-centric analysis is primed for continued progress given the numerous market want for digital transformation,” stated Wozniak. “My expertise scaling companies and accelerating progress has led me to Castor – to ship on the promise of enabling sooner, smarter, scientific analysis.”
“Castor has grown tremendously previously yr, and with Anna and Kimberly – we add two robust, strategic leaders to assist information us throughout this part of our progress,” stated Derk Arts, M.D., Ph.D., CEO & Founder, Castor. “I’m delighted to welcome Anna and Kimberly to Castor, each extremely expert professionals with many years of expertise inside these essential company operational areas to make sure we are able to proceed to efficiently assist researchers conduct simpler scientific trials on a world scale, whereas enhancing the affected person expertise.”
Be taught extra about Castor’s increasing management staff here. And, for those who’re serious about becoming a member of a passionate and collaborative group bringing scientific trials into the twenty first century, Castor is hiring.
Castor is a number one supplier of decentralized and hybrid scientific trial options to democratize analysis. With the highest-rated eClinical platform for decentralized and hybrid scientific trials, Castor’s plug-and-play platform affords speedy deployment at scale, enabling researchers to create a trial in a matter of clicks, with simple enrollment, consent, and real-world information seize.
Castor is bringing human-centered design to the scientific trial course of, from recruitment to evaluation, and enhancing the standard, safety, and reusability of knowledge for researchers worldwide.
For extra data, go to www.castoredc.com. Observe us on Twitter at @castor.